Rococo Co, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 12% Increase in Ordinary Profit for The Current Fiscal Year
5868 Rococo Co.Ltd. 【J-GAAP】
Earnings ReportRococo Co.Ltd. <5868> [TSE Std] announced its financial results after the market closed on February 14th (17:00). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 2.0% from the previous period to 441 million yen, although it exceeded the initial forecast of 360 million yen. In the fiscal year ending December 2025, the profit is expected to expand to 11.6% to 492 million yen. This will be the fifth consecutive term of revenue growth.
At the same time, the company increased the annual dividend for the previous term from 20 yen to 30 yen (compared to 20 yen in the prior term). For the current term, the company plans to remove the commemorative dividend of the previous term and set the dividend for this term at an ordinary dividend of 25 yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit surged 2.6 times that of the same period last year, reaching 190 million yen. The operating profit margin significantly improved from 4.6% in the same period last year to 9.1%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
7,175M | 480M | 450M | 289M | 110.0 | 20 | Feb 14, 2024 | J-GAAP |
|
|
7,803M | 426M | 441M | 278M | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
| YoY | +8.8% | -11.3% | -2.0% | -3.8% | -31.7% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 Guidance | 7,711M | 350M | 360M | 231M | 62.1 | 20 | Aug 14, 2024 | J-GAAP |
| Dec, 2024 Results | 7,803M | 426M | 441M | 278M | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
| Revision Rate | +1.2% | +21.7% | +22.5% | +20.3% | +20.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
3,766M | 45M | 43M | 11M | 3.2 | 0 | Aug 14, 2024 | J-GAAP |
|
Guidance
Jan - Jun, 2025
|
ー | ー | ー | ー | － | 0 | Feb 14, 2025 | J-GAAP |
| YoY | － | － | － | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
7,175M | 480M | 450M | 289M | 110.0 | 20 | Feb 14, 2024 | J-GAAP |
|
|
7,803M | 426M | 441M | 278M | 75.1 | 30 | Feb 14, 2025 | J-GAAP |
|
Guidance
Dec, 2025
|
8,610M | 496M | 492M | 331M | 88.8 | 25 | Feb 14, 2025 | J-GAAP |
| YoY | +10.3% | +16.4% | +11.6% | +19.1% | +18.3% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,850M | 86M | 74M | 39M | 14.8 | 4.6 | Feb 14, 2024 | J-GAAP |
|
|
1,941M | 122M | 126M | 80M | 21.9 | 6.3 | May 15, 2024 | J-GAAP |
|
|
1,825M | -77M | -83M | -69M | -19.9 | -4.2 | Aug 14, 2024 | J-GAAP |
|
|
1,944M | 190M | 208M | 145M | 39.4 | 9.8 | Nov 14, 2024 | J-GAAP |
|
|
2,093M | 191M | 190M | 122M | 32.9 | 9.1 | Feb 14, 2025 | J-GAAP |
| YoY | +13.1% | +122.1% | +156.8% | +212.8% | +122.0% |
Related Articles
-
ProjectHoldings, Break Evenin Ordinary Profit for The Current Fiscal Year
Fri Feb 14, 2025 5:50 pm JST Earnings -
NAKAYO, Postponed Dividend for This Fiscal Year
Fri Feb 14, 2025 3:30 pm JST Revision -
f-code, 42% Increase in Net Income, Update Record High for Third Consecutive Term
Fri Feb 14, 2025 5:30 pm JST Earnings -
Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Fri Feb 14, 2025 5:00 pm JST Earnings -
AEON Fantasy, The Current Fiscal Year Net Income Revised Downward to a Loss, Dividend Revised down by 5 yen
Fri Feb 14, 2025 5:00 pm JST Revision -
Scala, First Half Net Income Turns to Profit, Exceeds Full-Year Plan
Fri Feb 14, 2025 5:00 pm JST Earnings -
kaihan, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Fri Feb 14, 2025 5:00 pm JST Earnings -
baby calendar, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 60% Increase in Ordinary Profit for The Current Fiscal Year
Fri Feb 14, 2025 5:00 pm JST Earnings -
Daikokuya Holdings, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Fri Feb 14, 2025 5:00 pm JST Earnings -
Kanamic Network, Oct-Dec (1Q) Ordinary Profit Increases by 19%
Fri Feb 14, 2025 5:00 pm JST Earnings